Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI